Marine Drugs · 2018 · 80 citations · 38 references
MedicineOncologyPharmacologyApoptosisCancer PharmacologyMolecular OncologyCancer Cell SignalingCell-cycle DysregulationCancer Cell Proliferation InhibitionCancer Signaling PathwaysCell Cycle Arrest MechanismsCell Cycle InhibitorsCell Phenotype CharacterizationNf-kappa B-mediated Anti-apoptotic SignalingNf-κb SignalingNon-small Cell Lung Cancer Treatment
Phycocyanin, a type of functional food colorant, is shown to have a potent anti-cancer property. Non-small cell lung cancer (NSCLC) is one of the most aggressive form of cancers with few effective therapeutic options. Previous studies have demonstrated that phycocyanin exerts a growth inhibitory effect on NSCLC A549 cells. However, its biological function and underlying regulatory mechanism on other cells still remain unknown. Here, we investigated the in vitro function of phycocyanin on three typical NSCLC cell lines, NCI-H1299, NCI-H460, and LTEP-A2, for the first time. The results showed that phycocyanin could significantly induce apoptosis, cell cycle arrest, as well as suppress cell migration, proliferation, and the colony formation ability of NSCLC cells through regulating multiple key genes. Strikingly, phycocyanin was discovered to affect the cell phenotype through regulating the NF-κB signaling of NSCLC cells. Our findings demonstrated the anti-neoplastic function of phycocyanin and provided valuable information for the regulation of phycocyanin in NSCLC cells.
38
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
Global cancer statistics, 2012
Lindsey A. Torre, Freddie Bray, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians · 2015 · 27.4K citations · Full text
Rebecca L. Siegel, Deepa Naishadham, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2013 · 11.9K citations · Full text
Soluble Extract from Moringa oleifera Leaves with a New Anticancer Activity
Il Lae Jung · PLoS ONE · 2014 · 273 citations · Full text
Medicine, Oncology, Pharmacology +16